Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Bibliographic Details
Main Authors:	Adviti Naik, Joe Yeong, Julie Decock
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	cancer testis antigen cancer biology cancer biomarker cancer therapy immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/full

Similar Items

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: A. Naik, et al.
Published: (2023-02-01)

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi, et al.
Published: (2019-07-01)

Preferentially Expressed Antigen in Melanoma Is a Multifaceted Cancer Testis Antigen with Diverse Roles as a Biomarker and Therapeutic Target
by: Mukulika Bose
Published: (2023-08-01)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019-01-01)

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik, et al.
Published: (2022-02-01)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
by: Dawn Sijin Nin, et al.
Published: (2023-03-01)

Methylation Profile of Cancer Testis Antigens in Colorectal Cancer
by: Nadiah Abu, et al.
Published: (2023-03-01)

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
by: Ping Yang, et al.
Published: (2022-04-01)

Renal Cell Carcinoma: A Cancer-testis Antigen Poor Malignancy
by: Sepideh Faramarzi, et al.
Published: (2017-09-01)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik, et al.
Published: (2019-08-01)

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
by: Runyi Adeline Lam, et al.
Published: (2021-07-01)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
by: Ramilia Vlasenkova, et al.
Published: (2023-09-01)

Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: Jing Wu, et al.
Published: (2022-11-01)

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
by: Jin S, et al.
Published: (2018-07-01)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
by: Huihan Ai, et al.
Published: (2023-06-01)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
by: Mie K. Jakobsen, et al.
Published: (2020-09-01)

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
by: Yazarlou F, et al.
Published: (2018-11-01)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
by: Ai Miyamoto, et al.
Published: (2022-05-01)

Identification of cancer/testis antigens related to gastric cancer prognosis based on co-expression network and integrated transcriptome analyses
by: Sara Ansari, et al.
Published: (2023-01-01)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
by: Adviti Naik, et al.
Published: (2020-11-01)

Crosstalk between Stress Granules, Exosomes, Tumour Antigens, and Immune Cells: Significance for Cancer Immunity
by: Vinoth Kumar Kothandan, et al.
Published: (2020-04-01)

Cancer-Testis Gene Biomarkers Discovered in Colon Cancer Patients
by: Mikhlid H. Almutairi, et al.
Published: (2022-05-01)

Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer
by: Shiv Verma, et al.
Published: (2024-01-01)

Frequency of cancer testis antigens in chronic myeloid leukemia
by: I. Mendoza-Salas, et al.
Published: (2016-04-01)

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
by: Afsheen Raza, et al.
Published: (2020-03-01)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
by: Ye-Rin Kim, et al.
Published: (2021-05-01)

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma
by: Lisanne Noordam, et al.
Published: (2021-05-01)

Sperm-Associated Antigen 9 as a Candidate Diagnostic and Prognostic Biomarker in Breast Cancer
by: Houra Naraghi, et al.
Published: (2020-10-01)

Expression of cancer–testis antigens in the immune microenvironment of non‐small cell lung cancer
by: Feria Hikmet, et al.
Published: (2023-12-01)

Cancer/testis antigen‐Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway
by: Yongfei Li, et al.
Published: (2018-08-01)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
by: Bortoluzzo Adriana B, et al.
Published: (2011-09-01)

The Price of Human Evolution: Cancer-Testis Antigens, the Decline in Male Fertility and the Increase in Cancer
by: Jekaterina Erenpreisa, et al.
Published: (2023-07-01)

Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach
by: Ana María Hurtado López, et al.
Published: (2020-01-01)

Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
by: Yingyu Xu, et al.
Published: (2023-03-01)

EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
by: D. S. Kutilin, et al.
Published: (2019-07-01)

Cancer-testis genes in colon cancer
by: N R Hilal, et al.
Published: (2017-05-01)

Editorial: Cancer genomics in the era of precision medicine
by: Omar M. Khan, et al.
Published: (2024-02-01)

Co-expression of tumor suppressor p53 (TP53) and cancer testis antigens (CTAs) as the possible indicator of “cancer-free” status
by: D. Marjanidze, et al.
Published: (2023-01-01)

EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HELA CELLS
by: Denis Sergeevich Kutilin, et al.
Published: (2019-03-01)

Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
by: Kyeonghee Shim, et al.
Published: (2023-09-01)